Qualified Institutional Placement

September 17, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 001 Mumbai – 400 051 Scrip Code No: 542665 Company Symbol: NEOGEN Debt Segment Code: 977028 Re: Qualified institutions placement of equity shares of face value of ₹10 each (the “Equity Shares”) by Neogen Chemicals Limited (the “Company”) (the “QIP” or “Issue”) in terms of the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”), and Section 42 and Section 62 of the Companies Act, 2013, as amended (the “Companies Act”) read with the rules issued thereunder. Sub: Outcome of the meeting of the Fund-Raising Committee held on September 16, 2026 Dear Sir/Madam, Pursuant to the approval of the Board of Directors of the Company (the “Board”) at its meeting held on July 24, 2026, and approval of the shareholders of the Company by way of a special resolution passed on August 21, 2026 (the “Shareholders’ Approval”), and our letter dated September 10, 2026, and September 16, 2026, intimating you about the outcome of the meeting of the Fund-Raising Committee in respect of the QIP and the Issue which opened on September 10, 2026 and closed on September 16, 2026, we wish to further inform you that in respect of the QIP, the Fund-Raising Committee (the “Committee”), of the Company has, at its meeting held on September 16, 2026, which commenced at 11:50 p.m. and concluded at 11:55 p.m. inter alia, considered and approved the issue and allotment of 26,60,753 Equity Shares, to eligible QIBs at the issue price of ₹ 2,255 per Equity Share including a premium of ₹ 2,245 per Equity Share, which is higher than a floor price of ₹ 2189.73, aggregating to ₹ 5,99,99,98,015.00 (Rupees Five hundred ninety-nine crore ninety-nine lakh ninety-eight thousand and fifteen only), pursuant to the QIP. Pursuant to the allotment of Equity Shares under the QIP, the paid-up equity share capital of the Company stands increased from ₹27,38,16,740 consisting of 2,73,81,674 Equity Shares of ₹ 10 each to ₹30,04,24,270 consisting of 3,00,42,427 Equity Shares of ₹ 10 each. The shareholding pattern of the Company before and after the Issue, will be submitted along with listing application in the format specified in Regulation 31 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Issue opened on September 10, 2026 and closed on September 16, 2026 and the same was intimated to you through our letters dated September 10, 2026 and September 16, 2026, respectively. The equity shares allotted by the Company to the aforementioned investors shall be listed on BSE Limited and National Stock Exchange of India Limited and shall rank pari passu with the existing equity shares of the Company in all respects, including the payment of dividend and voting rights. The details required pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, with respect to the aforesaid QIP Issue is enclosed herewith as Annexure 1. Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 Further find attached herewith the list of allottees who have been allotted more than 5% of the Equity Shares offered in the Issue is available in Annexure 1 below. Copy of this intimation is also being made available on the website of our Company at https://neogenchem.com/announcements/ under the Issue of Securities Tab. The same may please be taken on record and suitably disseminated to all concerned. Thanking you, Yours faithfully, For Neogen Chemicals Limited Unnati Kanani Company Secretary and Compliance Officer Mem. No. A35131 Place: Thane Encl.: A/a Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 Annexure 1 Disclosure with respect to the QIP issue pursuant to the SEBI Circulars PARTICULARS DETAILS Type of securities to be issued Equity Shares of a Face Value of Rs. 10 each Type of issuance Qualified Institutional Placement in accordance with Chapter VI of the SEBI ICDR Regulations and other applicable laws Total number of securities to be issued Allotment of 26,60,753 Equity Shares, to eligible QIBs at the issue price or the total amount for which the of ₹ 2,255 per Equity Share including a premium of ₹ 2,245 per Equity securities will be issued (approximately) Share, which is higher than the floor price i.e. ₹ 2,189.73 calculated in accordance with Chapter VI of the SEBI ICDR Regulations, aggregating to ₹ 5,99,99,98,015.00 (Rupees Five hundred ninety nine crore ninety nine lakh ninety eight thousand and fifteen only). List of allottees who have been allotted more than 5% of the Equity Shares offered in the QIP: Sr No Name of the Allottees No. of Pan Club Perc Percentag Category Shares Shares enta e Allotted ge (PAN (%) Clubbed ) (5 %) and above 1 ICICI Prudential Commodities Fund 62,084 3,54,768 2.33 13.33 Mutual Fund ICICI PRUDENTIAL MID CAP FUND 70,954 2.67 Mutual Fund ICICI PRUDENTIAL MULTI CAP FUND 2,21,730 8.33 Mutual Fund 2 INVESCO INDIA SMALL CAP FUND . 3,16,757 3,54,768 11.9 13.33 Custodian 0 Mutual Fund INVESCO INDIA ELSS TAX SAVER FUND . 38,011 1.43 Custodian Mutual Fund 3 MIRAE ASSET AGGRESSIVE HYBRID FUND 1,73,906 3,54,768 6.54 13.33 Mutual Fund MIRAE ASSET EQUITY SAVINGS FUND 17,390 0.65 Mutual Fund MIRAE ASSET BALANCED ADVANTAGE 17,390 0.65 Mutual FUND Fund MIRAE ASSET MULTI ASSET ALLOCATION 34,782 1.31 Mutual FUND Fund MIRAE ASSET HEALTHCARE FUND 1,11,300 4.18 Custodian MIRAHCFD Mutual Fund 4 SBI LIFE INSURANCE CO. LTD 3,54,768 3,54,768 13.3 13.33 Insurance Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 3 Company registered with IRDA 5 WHITEOAK CAPITAL FLEXI CAP FUND 39,911 2,12,861 1.50 8.00 Mutual Fund WHITEOAK CAPITAL MID CAP FUND 84,257 3.17 Mutual Fund WHITEOAK CAPITAL ELSS TAX SAVER 1,421 0.05 Mutual FUND Fund WHITEOAK CAPITAL SPECIAL 25,499 0.96 Mutual OPPORTUNITIES FUND Fund WHITEOAK CAPITAL MULTI CAP FUND 55,432 2.08 Mutual Fund WHITEOAK CAPITAL AGGRESSIVE HYBRID 6,341 0.24 Mutual FUND Fund 6 AXIS MUTUAL FUND TRUSTEE LIMITED 1,04,344 1,77,384 3.92 6.67 Mutual A/C AXIS MUTUAL FUND A/C AXIS SMALL Fund CAP FUND AXIS MUTUAL FUND TRUSTEE LIMITED 31,303 1.18 Mutual A/C AXIS MUTUAL FUND A/C AXIS Fund INNOVATION FUND AXIS MUTUAL FUND TRUSTEE LIMITED 41,737 1.57 Mutual A/C AXIS MUTUAL FUND A/C AXIS Fund BUSINESS CYCLES FUND 7 ABU DHABI INVESTMENT AUTHORITY - 1,41,907 1,41,907 5.33 5.33 Foreign WAY Portfolio Investor (Corporate) Issue Price The issue price is ₹ 2,255 per Equity Share including a premium of ₹ 2,245 per Equity Share, which is higher than the floor price i.e. ₹ 2,189.73 calculated in accordance with Chapter VI of the SEBI ICDR Regulations, aggregating to ₹ 5,99,99,98,015.00 (Rupees Five hundred ninety nine crore ninety nine lakh ninety eight thousand and fifteen only). Thanking you, For Neogen Chemicals Limited Unnati Kanani Company Secretary & Compliance Officer Mem. No: A35131 Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919